Najafi Ramin
Insider CIK 1410081 · NBY Chief Executive Officer, Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NBY NovaBay Pharmaceuticals, I | P Buy | 2015-08-20 | 2015-08-21 | 6,000 | $0.44 | $2.6K | 12,000 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | P Buy | 2015-08-19 | 2015-08-21 | 6,000 | $0.50 | $3.0K | 6,000 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award | 2015-03-23 | 2015-03-25 | 46,033 | — | $0 | 3,437,699 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | P Buy deriv | 2015-03-03 | 2015-03-05 | 166,666 | $0.60 | $100.0K | 291,665 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | P Buy deriv | 2015-03-03 | 2015-03-05 | 124,999 | $0.65 | $81.2K | 291,665 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | P Buy | 2015-03-03 | 2015-03-05 | 166,666 | $0.60 | $100.0K | 3,391,666 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | P Buy | 2014-12-12 | 2014-12-15 | 50,000 | $0.65 | $32.5K | 0 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | P Buy | 2014-12-11 | 2014-12-11 | 20,000 | $0.60 | $12.0K | 3,175,000 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | P Buy | 2014-12-05 | 2014-12-08 | 25,000 | $0.65 | $16.3K | 3,155,000 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | P Buy | 2014-12-02 | 2014-12-04 | 18,000 | $0.71 | $12.8K | 3,130,000 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award deriv | 2014-09-26 | 2014-09-30 | 90,000 | — | $0 | 1,015,032 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | G Gift | 2014-06-02 | 2014-06-04 | 5,500 | — | $0 | 3,112,000 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award deriv | 2014-04-15 | 2014-04-17 | 10,180 | — | $0 | 925,032 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | F Tax w/h | 2013-10-28 | 2013-10-29 | 4,557 | $1.75 | $8.0K | 100,195 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award deriv | 2013-09-26 | 2013-10-02 | 150,000 | — | $0 | 914,852 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award deriv | 2013-01-10 | 2013-01-14 | 85,000 | — | $0 | 764,852 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | P Buy deriv | 2012-12-06 | 2012-12-10 | 15,000 | $0.01 | $150 | 15,000 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | P Buy | 2012-12-06 | 2012-12-10 | 20,000 | $1.24 | $24.8K | 100,195 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | F Tax w/h | 2012-10-27 | 2012-12-04 | 4,557 | $1.31 | $6.0K | 80,195 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award deriv | 2012-10-10 | 2012-10-12 | 65,000 | — | $0 | 679,852 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award deriv | 2012-09-26 | 2012-11-01 | 65,000 | — | $0 | 679,852 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | P Buy | 2012-05-29 | 2012-05-30 | 4,000 | $0.96 | $3.8K | 32,752 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | P Buy | 2012-05-29 | 2012-05-30 | 2,000 | $0.96 | $1.9K | 34,752 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | P Buy | 2012-05-25 | 2012-05-29 | 3,500 | $0.99 | $3.5K | 28,752 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award deriv | 2012-02-17 | 2012-02-23 | 96,652 | — | $0 | 614,852 | SEC↗ |